Novel urinary biomarkers in pre-diabetic nephropathy
Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed pr...
Saved in:
Published in | Clinical and experimental nephrology Vol. 19; no. 5; pp. 895 - 900 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.10.2015
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1342-1751 1437-7799 1437-7799 |
DOI | 10.1007/s10157-015-1085-3 |
Cover
Loading…
Abstract | Background
Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics.
Methods
A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin–creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated.
Results
Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL–creatinine ratio (UNCR) and urine Cystatin C–creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (
p
= 0.000) and 1.138 (
p
= 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria.
Conclusion
Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy. |
---|---|
AbstractList | Background
Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics.
Methods
A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin–creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated.
Results
Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL–creatinine ratio (UNCR) and urine Cystatin C–creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (
p
= 0.000) and 1.138 (
p
= 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria.
Conclusion
Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy. Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics. A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated. Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria. Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy. Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics. Methods A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated. Results Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria. Conclusion Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy. Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics.BACKGROUNDRenal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics.A total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated.METHODSA total of 91 subjects (diabetes 61 and pre-diabetes 30) were enrolled into the study. Urinary biomarkers such as urine Neutrophil Gelatinase-Associated Lipocalin (NGAL), urine Cystatin C and urine albumin-creatinine ratio (UACR) were estimated. Subjects were further divided in four groups on the basis of UACR: pre-diabetes with normoalbuminuria (21); pre-diabetes with microalbuminuria (9); diabetes with normoalbuminuria (37); and diabetes with microalbuminuria (24). The relationship of UACR, NGAL, and Cystatin C was estimated.Urine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria.RESULTSUrine levels of NGAL and Cystatin C were significantly higher in microalbuminuria group compared to normoalbuminuria. UACR was positively correlated to urine NGAL-creatinine ratio (UNCR) and urine Cystatin C-creatinine ratio (UCCR) in both diabetes and pre-diabetes. On logistic regression odds ratio of UNCR to predict microalbuminuria in diabetes and pre-diabetes was 1.070 (p = 0.000) and 1.138 (p = 0.010), respectively. Area under curve was determined by ROC analysis, and UNCR was found to be better than UCCR for estimating microalbuminuria.Tubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy.CONCLUSIONTubular damage may play major role in development of nephropathy in pre-diabetes. Newer markers like urine NGAL and Cystatin C are raised early in diabetes and pre-diabetes nephropathy. |
Author | Garg, Vikas Gadpayle, Adesh Kumar Chitkara, Anubhuti Mahapatra, Himansu Sekhar Kumar, Manish Sekhar, Venketansan |
Author_xml | – sequence: 1 givenname: Vikas surname: Garg fullname: Garg, Vikas organization: Room No 307, Admin Block, PGIMER – sequence: 2 givenname: Manish surname: Kumar fullname: Kumar, Manish organization: Room No 307, Admin Block, PGIMER – sequence: 3 givenname: Himansu Sekhar surname: Mahapatra fullname: Mahapatra, Himansu Sekhar email: hsmnephro@gmail.com organization: Room No 307, Admin Block, PGIMER – sequence: 4 givenname: Anubhuti surname: Chitkara fullname: Chitkara, Anubhuti organization: Room No 307, Admin Block, PGIMER – sequence: 5 givenname: Adesh Kumar surname: Gadpayle fullname: Gadpayle, Adesh Kumar organization: Room No 307, Admin Block, PGIMER – sequence: 6 givenname: Venketansan surname: Sekhar fullname: Sekhar, Venketansan organization: Room No 307, Admin Block, PGIMER |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25634253$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE1LxDAQhoMofv8AL1Lw4iWaSTpNehTxC0Qveg7ZNtVoN6lJK-y_N8uqiKCXmUCeJ5l5d8i6D94ScgDsBBiTpwkYoKS5UGAKqVgj21AKSaWs6_V8FiWnIBG2yE5KL4wxVWO9SbY4VvkKxTYp78K77YspOm_iopi5MDfx1cZUOF8M0dLWmZkdXVN4OzzHMJjxebFHNjrTJ7v_2XfJ4-XFw_k1vb2_ujk_u6UNchhpY3hnOdRlVRmBUDJRCYVcNmgVdI2pWStbwaxiNWCLhhkQolMz1SpAgUbskuPVu0MMb5NNo5671Ni-N96GKWmQnJec1xVm9OgX-hKm6PN0SwqUVIgsU4ef1DSb21YP0eV1F_orjwzACmhiSCna7hsBppeZ61XmOhe9zFwvHfnLadxoRhf8GI3r_zX5ykz5F_9k44-h_5Q-AHXmkiU |
CODEN | CENPFV |
CitedBy_id | crossref_primary_10_1007_s00125_018_4567_5 crossref_primary_10_3390_chemosensors11060350 crossref_primary_10_1016_j_cca_2018_10_021 crossref_primary_10_11613_BM_2024_020709 crossref_primary_10_3390_ijms22189985 crossref_primary_10_1038_s41598_017_02421_9 crossref_primary_10_1007_s11892_015_0708_0 crossref_primary_10_1016_j_cca_2024_119762 crossref_primary_10_1002_jcla_23487 crossref_primary_10_1007_s13410_020_00911_7 crossref_primary_10_4103_ijmr_IJMR_455_21 crossref_primary_10_1186_s12882_017_0620_8 crossref_primary_10_4103_ijn_IJN_67_20 crossref_primary_10_11613_BM_2019_010501 crossref_primary_10_1373_jalm_2018_028530 crossref_primary_10_51620_0869_2084_2021_66_10_593_602 crossref_primary_10_2147_DMSO_S247062 crossref_primary_10_1155_2016_4647685 crossref_primary_10_1053_j_ackd_2017_10_012 crossref_primary_10_1159_000505155 crossref_primary_10_1016_j_sintl_2023_100253 crossref_primary_10_1155_2016_4626125 crossref_primary_10_1097_XCE_0000000000000180 crossref_primary_10_1186_s40364_015_0042_3 crossref_primary_10_1111_dom_15518 crossref_primary_10_1210_jendso_bvae014 crossref_primary_10_1007_s12010_018_2919_8 crossref_primary_10_1159_000507858 crossref_primary_10_1186_s12896_018_0449_7 crossref_primary_10_2147_DMSO_S392888 crossref_primary_10_3390_ijms23158668 crossref_primary_10_5812_jjcdc_142750 crossref_primary_10_1002_ar_24835 crossref_primary_10_1016_j_dsx_2021_05_025 crossref_primary_10_1016_j_jcjd_2021_07_004 crossref_primary_10_3390_jcm9103289 crossref_primary_10_3389_fcell_2021_630401 crossref_primary_10_3389_fphar_2021_680336 crossref_primary_10_1016_j_bbapap_2020_140475 crossref_primary_10_1007_s13410_015_0461_6 crossref_primary_10_1007_s10544_020_00484_6 crossref_primary_10_1080_10408363_2017_1377682 crossref_primary_10_1016_j_dsx_2018_04_017 |
Cites_doi | 10.1503/cmaj.061590 10.1053/ajkd.2002.34487 10.7326/0003-4819-130-6-199903160-00002 10.1152/ajprenal.00142.2008 10.1056/NEJMoa0806470 10.1681/ASN.2006040368 10.1159/000078452 10.2337/dc09-1098 10.3346/jkms.2011.26.2.258 10.2337/dc14-S081 10.1681/ASN.2005121324 10.1111/j.1752-8062.2008.00053.x 10.1016/j.clinbiochem.2004.09.025 10.1152/ajpendo.00299.2007 10.1016/S0140-6736(99)12323-7 10.2337/dc13-0985 10.1001/jama.289.24.3273 10.2337/dc10-1545 10.1053/j.ajkd.2012.07.005 10.1016/j.diabres.2011.09.031 10.1053/j.ackd.2005.01.008 10.1007/s12020-011-9509-7 10.1016/j.bbrc.2007.04.072 10.1515/CCLM.2006.050 10.1097/01.ASN.0000088027.54400.C6 10.1016/j.clinbiochem.2013.05.072 10.1172/JCI23056 10.1111/j.1464-5491.2010.03083.x 10.1016/S0272-6386(04)01079-0 10.1007/s00592-013-0485-7 10.1152/ajprenal.00008.2003 10.2337/diab.37.5.532 10.4093/dmj.2012.36.4.307 10.2337/dc12-0849 10.1016/S0140-6736(05)74811-X 10.3892/etm.2013.1315 |
ContentType | Journal Article |
Copyright | Japanese Society of Nephrology 2015 |
Copyright_xml | – notice: Japanese Society of Nephrology 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s10157-015-1085-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Academic Middle East (New) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1437-7799 |
EndPage | 900 |
ExternalDocumentID | 3835158511 25634253 10_1007_s10157_015_1085_3 |
Genre | Journal Article |
GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 203 29B 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM OVD P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 PZZ Q2X QOR QOS R89 R9I RNI ROL RPX RRX RSV RZK S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z81 Z82 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7QP 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c521t-ca2fe219466a351403638527c5e81fca90d7d30e80915d5a0a133f8b8d81535a3 |
IEDL.DBID | U2A |
ISSN | 1342-1751 1437-7799 |
IngestDate | Tue Aug 05 10:00:25 EDT 2025 Sat Aug 16 07:51:09 EDT 2025 Mon Jul 21 06:05:01 EDT 2025 Tue Jul 01 03:35:48 EDT 2025 Thu Apr 24 23:04:10 EDT 2025 Fri Feb 21 02:33:27 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | NGAL Diabetic nephropathy Pre-diabetes Cystatin C |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c521t-ca2fe219466a351403638527c5e81fca90d7d30e80915d5a0a133f8b8d81535a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 25634253 |
PQID | 1721878550 |
PQPubID | 43386 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1722422965 proquest_journals_1721878550 pubmed_primary_25634253 crossref_primary_10_1007_s10157_015_1085_3 crossref_citationtrail_10_1007_s10157_015_1085_3 springer_journals_10_1007_s10157_015_1085_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-10-01 |
PublicationDateYYYYMMDD | 2015-10-01 |
PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationSubtitle | Official Publication of the Japanese Society of Nephrology |
PublicationTitle | Clinical and experimental nephrology |
PublicationTitleAbbrev | Clin Exp Nephrol |
PublicationTitleAlternate | Clin Exp Nephrol |
PublicationYear | 2015 |
Publisher | Springer Japan Springer Nature B.V |
Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
References | Mishra, Ma, Prada, Mitsnefes (CR14) 2003; 14 Makris, Nikolaki, Nanopoulos, Pirqakis (CR29) 2013; 46 Kramer, Nguyen, Curhan, Hsu (CR6) 2003; 289 Jeon, Kim, Huh, Mok (CR9) 2011; 26 Russo, Sandoval, Campos (CR38) 2006; 17 Mishra, Mori, Ma, Kelly, Barasch, Devarajan (CR15) 2004; 24 Tapp, Shaw, Zimmet, Balkau (CR26) 2004; 44 Fu, Xiong, Fang, Wen (CR34) 2012; 41 Duncan, Walker, Ezzat, Wheatcroft (CR28) 2007; 293 Thomas, Burns, Cooper (CR2) 2005; 12 Mori, Lee, Rapoport, Drexler (CR35) 2005; 115 Kim, Song, Kim, Jeon (CR17) 2013; 36 Fu, Li, Wang, Chen (CR20) 2012; 95 Yang, Mori, Li, Barasch (CR13) 2003; 285 Remuzzi, Macia, Ruggenenti (CR22) 2006; 17 Comper, Hilliard, Nikolic-Paterson, Russo (CR3) 2008; 295 Tarsio, Reger, Furcht (CR27) 1988; 37 Assal, Tawfeek, Rasheed, Lebedy (CR33) 2013; 6 Krolewski, Niewczas, Skupien (CR4) 2014; 37 Molitch, Steffes, Sun (CR5) 2010; 33 (CR7) 2012; 60 Wu, Ding, Zhu, Shao (CR19) 2013; 6 Woo, Choi, Kim, Kim (CR31) 2012; 36 Dharnidharka, Kwon, Stevens (CR11) 2002; 40 Nauta, Boertien, Bakker, Goor (CR18) 2011; 34 Filler, Bokenkamp, Hofmann, Le Bricon (CR12) 2005; 38 Levey, Bosch, Lewis, Green (CR25) 1999; 130 (CR23) 2000; 355 Nielsen, Schjoedt, Astrup, Tarnow (CR10) 2010; 27 Kaseda, Iino, Hosojima, Takeda (CR36) 2007; 357 Holman, Paul, Bethel, Matthews (CR21) 2008; 359 CR24 (CR1) 2014; 37 Barratt, Topham (CR8) 2007; 177 Conti, Moutereau, Zater, Lallali (CR30) 2006; 44 Mishra, Dent, Tarabishi, Mitsnefes (CR16) 2005; 365 Vaidya, Waikar, Ferguson (CR37) 2008; 1 Lacquaniti, Donato, Pintaudi, Vieste (CR32) 2013; 50 WD Comper (1085_CR3) 2008; 295 J Barratt (1085_CR8) 2007; 177 WJ Fu (1085_CR34) 2012; 41 HJ Kramer (1085_CR6) 2003; 289 J Yang (1085_CR13) 2003; 285 WJ Fu (1085_CR20) 2012; 95 J Mishra (1085_CR14) 2003; 14 FL Nauta (1085_CR18) 2011; 34 1085_CR24 KS Woo (1085_CR31) 2012; 36 J Mishra (1085_CR16) 2005; 365 SE Nielsen (1085_CR10) 2010; 27 RR Holman (1085_CR21) 2008; 359 RJ Tapp (1085_CR26) 2004; 44 National Kidney Foundation (1085_CR7) 2012; 60 M Conti (1085_CR30) 2006; 44 AS Levey (1085_CR25) 1999; 130 K Mori (1085_CR35) 2005; 115 G Filler (1085_CR12) 2005; 38 J Wu (1085_CR19) 2013; 6 LM Russo (1085_CR38) 2006; 17 Heart Outcomes Prevention Evaluation Study Investigators (1085_CR23) 2000; 355 K Makris (1085_CR29) 2013; 46 R Kaseda (1085_CR36) 2007; 357 ME Molitch (1085_CR5) 2010; 33 J Mishra (1085_CR15) 2004; 24 AS Krolewski (1085_CR4) 2014; 37 SS Kim (1085_CR17) 2013; 36 VS Vaidya (1085_CR37) 2008; 1 JF Tarsio (1085_CR27) 1988; 37 YK Jeon (1085_CR9) 2011; 26 MC Thomas (1085_CR2) 2005; 12 American Diabetes Association (1085_CR1) 2014; 37 ER Duncan (1085_CR28) 2007; 293 A Lacquaniti (1085_CR32) 2013; 50 VR Dharnidharka (1085_CR11) 2002; 40 G Remuzzi (1085_CR22) 2006; 17 HS Assal (1085_CR33) 2013; 6 22950063 - Diabetes Metab J. 2012 Aug;36(4):307-13 21779943 - Endocrine. 2012 Feb;41(1):82-8 19118149 - J Am Soc Nephrol. 2009 Mar;20(3):489-94 21286018 - J Korean Med Sci. 2011 Feb;26(2):258-63 15607309 - Clin Biochem. 2005 Jan;38(1):1-8 17698825 - CMAJ. 2007 Aug 14;177(4):361-8 15822053 - Adv Chronic Kidney Dis. 2005 Apr;12(2):177-86 15711640 - J Clin Invest. 2005 Mar;115(3):610-21 22015481 - Diabetes Res Clin Pract. 2012 Jan;95(1):105-9 20413518 - Diabetes Care. 2010 Jul;33(7):1536-43 10075613 - Ann Intern Med. 1999 Mar 16;130(6):461-70 15492944 - Am J Kidney Dis. 2004 Nov;44(5):792-8 23067652 - Am J Kidney Dis. 2012 Nov;60(5):850-86 23754672 - Acta Diabetol. 2013 Dec;50(6):935-42 17711985 - Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1311-9 21307379 - Diabetes Care. 2011 Apr;34(4):975-81 14514731 - J Am Soc Nephrol. 2003 Oct;14 (10 ):2534-43 10675071 - Lancet. 2000 Jan 22;355(9200):253-9 16565256 - J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S90-7 16519600 - Clin Chem Lab Med. 2006;44(3):288-91 17462596 - Biochem Biophys Res Commun. 2007 Jun 15;357(4):1130-4 18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89 23966807 - Clin Med Insights Endocrinol Diabetes. 2013 Jul 31;6:7-13 12824208 - JAMA. 2003 Jun 25;289(24):3273-7 23093662 - Diabetes Care. 2013 Mar;36(3):656-61 3360214 - Diabetes. 1988 May;37(5):532-9 24250725 - Exp Ther Med. 2013 Dec;6(6):1482-1488 20854382 - Diabet Med. 2010 Oct;27(10 ):1144-50 12788784 - Am J Physiol Renal Physiol. 2003 Jul;285(1):F9-18 24357215 - Diabetes Care. 2014 Jan;37 Suppl 1:S81-90 18579704 - Am J Physiol Renal Physiol. 2008 Dec;295(6):F1589-600 23770456 - Clin Biochem. 2013 Aug;46(12):1128-30 19212447 - Clin Transl Sci. 2008 Dec;1(3):200-8 15811456 - Lancet. 2005 Apr 2-8;365(9466):1231-8 23939543 - Diabetes Care. 2014;37(1):226-34 12148093 - Am J Kidney Dis. 2002 Aug;40(2):221-6 15148457 - Am J Nephrol. 2004 May-Jun;24(3):307-15 |
References_xml | – volume: 177 start-page: 361 year: 2007 end-page: 368 ident: CR8 article-title: Urine proteomics: the present and future of measuring urinary protein components in disease publication-title: CMAJ. doi: 10.1503/cmaj.061590 – volume: 40 start-page: 221 year: 2002 end-page: 226 ident: CR11 article-title: Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis publication-title: Am J Kidney Dis. doi: 10.1053/ajkd.2002.34487 – volume: 130 start-page: 461 year: 1999 end-page: 470 ident: CR25 article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group publication-title: Ann Intern Med. doi: 10.7326/0003-4819-130-6-199903160-00002 – volume: 295 start-page: F1589 year: 2008 end-page: F1600 ident: CR3 article-title: Disease dependent mechanism of albuminuria publication-title: Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00142.2008 – volume: 359 start-page: 1577 year: 2008 end-page: 1589 ident: CR21 article-title: 10-year follow-up of intensive glucose control in type 2 diabetes publication-title: N Engl J Med. doi: 10.1056/NEJMoa0806470 – volume: 17 start-page: 2937 year: 2006 end-page: 2944 ident: CR38 article-title: Impaired tubular uptake explains albuminuria in early diabetic nephropathy publication-title: J Am Soc Nephrol. doi: 10.1681/ASN.2006040368 – volume: 24 start-page: 307 year: 2004 end-page: 315 ident: CR15 article-title: Neutrophil gelatinase associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity publication-title: Am J Nephrol. doi: 10.1159/000078452 – volume: 33 start-page: 1536 year: 2010 end-page: 1543 ident: CR5 article-title: Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study publication-title: Diabetes Care. doi: 10.2337/dc09-1098 – volume: 26 start-page: 258 year: 2011 end-page: 263 ident: CR9 article-title: Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes publication-title: J Korean Med Sci. doi: 10.3346/jkms.2011.26.2.258 – volume: 37 start-page: s81 year: 2014 end-page: s90 ident: CR1 article-title: Diagnosis and classification of diabetes mellitus publication-title: Diabetes Care. doi: 10.2337/dc14-S081 – volume: 17 start-page: S90 issue: S2 year: 2006 end-page: S97 ident: CR22 article-title: Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study publication-title: J Am Soc Nephrol. doi: 10.1681/ASN.2005121324 – volume: 1 start-page: 200 issue: 3 year: 2008 end-page: 208 ident: CR37 article-title: Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans publication-title: Clin Transl Sci. doi: 10.1111/j.1752-8062.2008.00053.x – volume: 38 start-page: 1 year: 2005 end-page: 8 ident: CR12 article-title: Cystatin C as a marker of GFR -history, indications, and future research publication-title: Clin Biochem. doi: 10.1016/j.clinbiochem.2004.09.025 – volume: 293 start-page: E1311 year: 2007 end-page: E1319 ident: CR28 article-title: Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species publication-title: Am J Physiol Endocrinol Metab. doi: 10.1152/ajpendo.00299.2007 – volume: 355 start-page: 253 year: 2000 end-page: 259 ident: CR23 article-title: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy publication-title: Lancet. doi: 10.1016/S0140-6736(99)12323-7 – volume: 37 start-page: 226 year: 2014 end-page: 234 ident: CR4 article-title: Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria publication-title: Diabetes Care. doi: 10.2337/dc13-0985 – volume: 289 start-page: 3273 year: 2003 end-page: 3277 ident: CR6 article-title: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus publication-title: JAMA. doi: 10.1001/jama.289.24.3273 – volume: 34 start-page: 975 year: 2011 end-page: 981 ident: CR18 article-title: Glomerular markers are elevated in patients with diabetes publication-title: Diabetes Care. doi: 10.2337/dc10-1545 – volume: 60 start-page: 850 year: 2012 end-page: 886 ident: CR7 article-title: KDOQI clinical practice guideline for diabetes and CKD: 2012 update publication-title: Am J Kidney Dis. doi: 10.1053/j.ajkd.2012.07.005 – volume: 95 start-page: 105 issue: 1 year: 2012 end-page: 109 ident: CR20 article-title: Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration publication-title: Diabetes Res Clin Pract. doi: 10.1016/j.diabres.2011.09.031 – volume: 12 start-page: 177 year: 2005 end-page: 186 ident: CR2 article-title: Tubular changes in early diabetic nephropathy publication-title: Adv Chronic Kidney Dis. doi: 10.1053/j.ackd.2005.01.008 – volume: 41 start-page: 82 issue: 1 year: 2012 end-page: 88 ident: CR34 article-title: Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study publication-title: Endocrine. doi: 10.1007/s12020-011-9509-7 – volume: 357 start-page: 1130 issue: 4 year: 2007 end-page: 1134 ident: CR36 article-title: Megalin-mediated endocytosis of cystatin C in proximal tubule cells publication-title: Biochem Biophys Res Commun. doi: 10.1016/j.bbrc.2007.04.072 – volume: 44 start-page: 288 issue: 3 year: 2006 end-page: 291 ident: CR30 article-title: Urinary Cystatin C as a specific marker of tubular dysfunction publication-title: Clin Chem Lab Med. doi: 10.1515/CCLM.2006.050 – volume: 6 start-page: 1482 year: 2013 end-page: 1488 ident: CR19 article-title: Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes publication-title: Exp Ther Med. – volume: 14 start-page: 2534 year: 2003 end-page: 2543 ident: CR14 article-title: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury publication-title: J Am Soc Nephrol. doi: 10.1097/01.ASN.0000088027.54400.C6 – volume: 46 start-page: 1128 issue: 12 year: 2013 end-page: 1130 ident: CR29 article-title: Measurement of Cystatin C in human urine by particle enhanced turbidimetric immunoassay on automated biochemistry analyzer publication-title: Clin Biochem. doi: 10.1016/j.clinbiochem.2013.05.072 – volume: 115 start-page: 610 issue: 3 year: 2005 end-page: 621 ident: CR35 article-title: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury publication-title: J Clin Invest. doi: 10.1172/JCI23056 – volume: 27 start-page: 1144 issue: 10 year: 2010 end-page: 1150 ident: CR10 article-title: Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril publication-title: Diabet Med. doi: 10.1111/j.1464-5491.2010.03083.x – volume: 6 start-page: 7 year: 2013 end-page: 13 ident: CR33 article-title: Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus publication-title: Clin Med Insights Endocrinol Diab. – volume: 44 start-page: 792 issue: 5 year: 2004 end-page: 798 ident: CR26 article-title: Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) publication-title: Am J Kidney Dis. doi: 10.1016/S0272-6386(04)01079-0 – volume: 50 start-page: 935 year: 2013 end-page: 942 ident: CR32 article-title: ‘‘Normoalbuminuric’’ diabetic nephropathy: tubular damage and NGAL publication-title: Acta Diabetol. doi: 10.1007/s00592-013-0485-7 – volume: 285 start-page: F9 year: 2003 end-page: F18 ident: CR13 article-title: Iron, lipocalin, and kidney epithelia publication-title: Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00008.2003 – volume: 37 start-page: 532 issue: 5 year: 1988 end-page: 539 ident: CR27 article-title: Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association publication-title: Diabetes. doi: 10.2337/diab.37.5.532 – volume: 36 start-page: 307 year: 2012 end-page: 313 ident: CR31 article-title: Urinary neutrophil gelatinase-associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease publication-title: Diabetes Metab J. doi: 10.4093/dmj.2012.36.4.307 – volume: 36 start-page: 656 year: 2013 end-page: 661 ident: CR17 article-title: Urinary Cystatin C and Tubular proteinuria predict progression of diabetic nephropathy publication-title: Diabetes Care. doi: 10.2337/dc12-0849 – ident: CR24 – volume: 365 start-page: 1231 year: 2005 end-page: 1238 ident: CR16 article-title: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery publication-title: Lancet. doi: 10.1016/S0140-6736(05)74811-X – volume: 37 start-page: s81 year: 2014 ident: 1085_CR1 publication-title: Diabetes Care. doi: 10.2337/dc14-S081 – volume: 24 start-page: 307 year: 2004 ident: 1085_CR15 publication-title: Am J Nephrol. doi: 10.1159/000078452 – volume: 95 start-page: 105 issue: 1 year: 2012 ident: 1085_CR20 publication-title: Diabetes Res Clin Pract. doi: 10.1016/j.diabres.2011.09.031 – volume: 14 start-page: 2534 year: 2003 ident: 1085_CR14 publication-title: J Am Soc Nephrol. doi: 10.1097/01.ASN.0000088027.54400.C6 – volume: 6 start-page: 7 year: 2013 ident: 1085_CR33 publication-title: Clin Med Insights Endocrinol Diab. – volume: 44 start-page: 792 issue: 5 year: 2004 ident: 1085_CR26 publication-title: Am J Kidney Dis. doi: 10.1016/S0272-6386(04)01079-0 – volume: 36 start-page: 307 year: 2012 ident: 1085_CR31 publication-title: Diabetes Metab J. doi: 10.4093/dmj.2012.36.4.307 – volume: 365 start-page: 1231 year: 2005 ident: 1085_CR16 publication-title: Lancet. doi: 10.1016/S0140-6736(05)74811-X – volume: 46 start-page: 1128 issue: 12 year: 2013 ident: 1085_CR29 publication-title: Clin Biochem. doi: 10.1016/j.clinbiochem.2013.05.072 – volume: 60 start-page: 850 year: 2012 ident: 1085_CR7 publication-title: Am J Kidney Dis. doi: 10.1053/j.ajkd.2012.07.005 – volume: 6 start-page: 1482 year: 2013 ident: 1085_CR19 publication-title: Exp Ther Med. doi: 10.3892/etm.2013.1315 – volume: 359 start-page: 1577 year: 2008 ident: 1085_CR21 publication-title: N Engl J Med. doi: 10.1056/NEJMoa0806470 – volume: 17 start-page: S90 issue: S2 year: 2006 ident: 1085_CR22 publication-title: J Am Soc Nephrol. doi: 10.1681/ASN.2005121324 – volume: 1 start-page: 200 issue: 3 year: 2008 ident: 1085_CR37 publication-title: Clin Transl Sci. doi: 10.1111/j.1752-8062.2008.00053.x – volume: 41 start-page: 82 issue: 1 year: 2012 ident: 1085_CR34 publication-title: Endocrine. doi: 10.1007/s12020-011-9509-7 – volume: 17 start-page: 2937 year: 2006 ident: 1085_CR38 publication-title: J Am Soc Nephrol. doi: 10.1681/ASN.2006040368 – volume: 34 start-page: 975 year: 2011 ident: 1085_CR18 publication-title: Diabetes Care. doi: 10.2337/dc10-1545 – volume: 40 start-page: 221 year: 2002 ident: 1085_CR11 publication-title: Am J Kidney Dis. doi: 10.1053/ajkd.2002.34487 – volume: 130 start-page: 461 year: 1999 ident: 1085_CR25 publication-title: Ann Intern Med. doi: 10.7326/0003-4819-130-6-199903160-00002 – volume: 357 start-page: 1130 issue: 4 year: 2007 ident: 1085_CR36 publication-title: Biochem Biophys Res Commun. doi: 10.1016/j.bbrc.2007.04.072 – volume: 293 start-page: E1311 year: 2007 ident: 1085_CR28 publication-title: Am J Physiol Endocrinol Metab. doi: 10.1152/ajpendo.00299.2007 – volume: 33 start-page: 1536 year: 2010 ident: 1085_CR5 publication-title: Diabetes Care. doi: 10.2337/dc09-1098 – volume: 27 start-page: 1144 issue: 10 year: 2010 ident: 1085_CR10 publication-title: Diabet Med. doi: 10.1111/j.1464-5491.2010.03083.x – volume: 37 start-page: 532 issue: 5 year: 1988 ident: 1085_CR27 publication-title: Diabetes. doi: 10.2337/diab.37.5.532 – volume: 177 start-page: 361 year: 2007 ident: 1085_CR8 publication-title: CMAJ. doi: 10.1503/cmaj.061590 – volume: 115 start-page: 610 issue: 3 year: 2005 ident: 1085_CR35 publication-title: J Clin Invest. doi: 10.1172/JCI23056 – volume: 38 start-page: 1 year: 2005 ident: 1085_CR12 publication-title: Clin Biochem. doi: 10.1016/j.clinbiochem.2004.09.025 – volume: 50 start-page: 935 year: 2013 ident: 1085_CR32 publication-title: Acta Diabetol. doi: 10.1007/s00592-013-0485-7 – volume: 295 start-page: F1589 year: 2008 ident: 1085_CR3 publication-title: Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00142.2008 – volume: 355 start-page: 253 year: 2000 ident: 1085_CR23 publication-title: Lancet. doi: 10.1016/S0140-6736(99)12323-7 – volume: 36 start-page: 656 year: 2013 ident: 1085_CR17 publication-title: Diabetes Care. doi: 10.2337/dc12-0849 – volume: 44 start-page: 288 issue: 3 year: 2006 ident: 1085_CR30 publication-title: Clin Chem Lab Med. doi: 10.1515/CCLM.2006.050 – volume: 289 start-page: 3273 year: 2003 ident: 1085_CR6 publication-title: JAMA. doi: 10.1001/jama.289.24.3273 – volume: 12 start-page: 177 year: 2005 ident: 1085_CR2 publication-title: Adv Chronic Kidney Dis. doi: 10.1053/j.ackd.2005.01.008 – volume: 37 start-page: 226 year: 2014 ident: 1085_CR4 publication-title: Diabetes Care. doi: 10.2337/dc13-0985 – volume: 26 start-page: 258 year: 2011 ident: 1085_CR9 publication-title: J Korean Med Sci. doi: 10.3346/jkms.2011.26.2.258 – ident: 1085_CR24 – volume: 285 start-page: F9 year: 2003 ident: 1085_CR13 publication-title: Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00008.2003 – reference: 16565256 - J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S90-7 – reference: 17698825 - CMAJ. 2007 Aug 14;177(4):361-8 – reference: 12148093 - Am J Kidney Dis. 2002 Aug;40(2):221-6 – reference: 14514731 - J Am Soc Nephrol. 2003 Oct;14 (10 ):2534-43 – reference: 23939543 - Diabetes Care. 2014;37(1):226-34 – reference: 16519600 - Clin Chem Lab Med. 2006;44(3):288-91 – reference: 24250725 - Exp Ther Med. 2013 Dec;6(6):1482-1488 – reference: 20854382 - Diabet Med. 2010 Oct;27(10 ):1144-50 – reference: 15811456 - Lancet. 2005 Apr 2-8;365(9466):1231-8 – reference: 23093662 - Diabetes Care. 2013 Mar;36(3):656-61 – reference: 17711985 - Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1311-9 – reference: 23754672 - Acta Diabetol. 2013 Dec;50(6):935-42 – reference: 21779943 - Endocrine. 2012 Feb;41(1):82-8 – reference: 15492944 - Am J Kidney Dis. 2004 Nov;44(5):792-8 – reference: 23770456 - Clin Biochem. 2013 Aug;46(12):1128-30 – reference: 19212447 - Clin Transl Sci. 2008 Dec;1(3):200-8 – reference: 12824208 - JAMA. 2003 Jun 25;289(24):3273-7 – reference: 15822053 - Adv Chronic Kidney Dis. 2005 Apr;12(2):177-86 – reference: 21307379 - Diabetes Care. 2011 Apr;34(4):975-81 – reference: 23966807 - Clin Med Insights Endocrinol Diabetes. 2013 Jul 31;6:7-13 – reference: 23067652 - Am J Kidney Dis. 2012 Nov;60(5):850-86 – reference: 22950063 - Diabetes Metab J. 2012 Aug;36(4):307-13 – reference: 3360214 - Diabetes. 1988 May;37(5):532-9 – reference: 21286018 - J Korean Med Sci. 2011 Feb;26(2):258-63 – reference: 17462596 - Biochem Biophys Res Commun. 2007 Jun 15;357(4):1130-4 – reference: 18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89 – reference: 12788784 - Am J Physiol Renal Physiol. 2003 Jul;285(1):F9-18 – reference: 20413518 - Diabetes Care. 2010 Jul;33(7):1536-43 – reference: 15607309 - Clin Biochem. 2005 Jan;38(1):1-8 – reference: 15148457 - Am J Nephrol. 2004 May-Jun;24(3):307-15 – reference: 24357215 - Diabetes Care. 2014 Jan;37 Suppl 1:S81-90 – reference: 22015481 - Diabetes Res Clin Pract. 2012 Jan;95(1):105-9 – reference: 10075613 - Ann Intern Med. 1999 Mar 16;130(6):461-70 – reference: 19118149 - J Am Soc Nephrol. 2009 Mar;20(3):489-94 – reference: 10675071 - Lancet. 2000 Jan 22;355(9200):253-9 – reference: 18579704 - Am J Physiol Renal Physiol. 2008 Dec;295(6):F1589-600 – reference: 15711640 - J Clin Invest. 2005 Mar;115(3):610-21 |
SSID | ssj0008959 |
Score | 2.2816105 |
Snippet | Background
Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the... Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes... Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 895 |
SubjectTerms | Acute-Phase Proteins - urine Adult Albuminuria - urine Biomarkers - urine Creatinine - urine Cystatin C - urine Diabetic Nephropathies - urine Female Humans Kidney Function Tests Lipids - blood Lipocalin-2 Lipocalins - urine Male Medicine Medicine & Public Health Middle Aged Nephrology Original Article Prediabetic State - urine Proto-Oncogene Proteins - urine Urology |
SummonAdditionalLinks | – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB60gngRbX1Uq0QQD8rivrKbnqSIpQjtyUJvSzabQKHu1j6E_ntn9tEqxV72stlsyEwmk5kv3wDcmyTgKqSsv9G25ROAMCbaSk_YSjtSC51TCvUHQW_ov4_4qAy4zUtYZWUTc0OdZIpi5M90VBEh0W-9TL8sqhpF2dWyhMY-HBB1GUG6wtH6wGWLdl4szfF818Jt0qmymsXVOYcT6JJ4OAW3vL_70pazuZUozfef7gkcl44j6xSSPoU9ndah0Unx0Py5Yg8sh3LmMfI6HPbLjHkD_EH2rSeMYupytmJ0254AObM5G6eMICBF8HWsWKqnVDIBPcLVGQy7bx-vPauslGApKkhgKekajbbHDwJJ0HzKzgruhopr4Rgl23YSJp6tBXoHPOHSlng0NSIWiUCLx6V3DrU0S_UlMONox_jtUCt0TXwTy1DFVJ3GBNxLUHhNsKt5ilRJI07VLCbRhgCZpjbCB7GP8shrwuP6k2nBobGrcaua_KhcTvNoI_wm3K1f40Kg7IZMdbbM26C74bYD3oSLQmjrv6FfhzrAsfOnSoq_Ov9vKFe7h3INR26hP6hGLagtZkt9gx7KIr7N1fAHN-_dlQ priority: 102 providerName: ProQuest |
Title | Novel urinary biomarkers in pre-diabetic nephropathy |
URI | https://link.springer.com/article/10.1007/s10157-015-1085-3 https://www.ncbi.nlm.nih.gov/pubmed/25634253 https://www.proquest.com/docview/1721878550 https://www.proquest.com/docview/1722422965 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB5sC-JF1PqIj7KCeFACeW2yPVapimIRsVBPYbPZhUJNpbVC_70zedSKD_CSHLLZLDuT2W92Zr8BODFpyFVEUX-jHTugBMKEaCt94SjtSi10Til03wtv-sHtgA_Kc9zTKtu9CknmlnrpsJvLKU2SmDMFt_0aNDi57qjEfa-zML-inVdIc_3As3FtdKtQ5k9dfF2MviHMb9HRfNG52oD1Ei2yTiHeTVjR2RY0Oxl6yi9zdsry_M18Y3wLVu_LMHkTgt74XY8YbaTLyZzREXvKwplM2TBjlPdR7LgOFcv0K9VJQBg434b-Vffp8sYuyyPYiqoQ2Ep6RqPBCcJQUj4-hWQF9yLFtXCNkm0njVLf0QIhAU-5dCT6o0YkIhVo5rj0d6CejTO9B8y42jVBO9IK8UhgEhmphErSmJD7KUrMAqeap1iV3OFUwmIUf7Ie09TGeCHKUR77FpwtXnktiDP-anxYTX5c_kPTmJxTERHhmgXHi8eo_RTSkJkez_I2iDG8dsgt2C2EtvgagjnUAY6dn1dSXOr8t6Hs_6v1Aax5hTqhVh1C_W0y00eIUt6SFtSiQdSCRuf6-a6L94tu7-GxlevqB-5T3hs |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZS8QwEB50BfVFvF3PCOqDUuyVNvsg4sl67CKi4FtN0wQWtLvuerB_yt_oTI9VEX3zpS9N0zCZmcyVbwA2TBJwFVLW32jb8qmAMCbYSk_YSjtSC51BCjWaQf3WP7_jd0PwXt6FobLKUidmijppK4qR75KrIkKC39rvPFnUNYqyq2ULjZwtLnT_DV223t7ZMe7vpuuentwc1a2iq4ClCLzfUtI1GuXUDwJJZeyUyRTcDRXXwjFK1uwkTDxbCzxJecKlLdGNMyIWiUDtwKWH8w7DiO-hK1OBkcOT5tX1QPeLWtaezfF818KD2SnzqPllPYdTmSchfwpued9Pwh_m7Y_UbHbinU7CRGGqsoOct6ZgSKfTMHOQopv-2GdbLCsezaLy0zDaKHL0M-A326_6gVEUX3b7jO73UwlQt8daKaOikzzc21Is1R1q0oA2aH8Wbv-FinNQSdupXgBmHO0YvxZqhcaQb2IZqpj64ZiAewmySxXskk6RKoDLqX_GQ_QJuUykjfBBeKc88qqwPfikk6N2_DV4uSR-VAhwL_pktyqsD16j6FE-Raa6_ZKNQQPHrQW8CvP5pg3-hpYk8gDHyXfKXfwy-W9LWfx7KWswVr9pXEaXZ82LJRh3c15CllqGynP3Ra-gffQcrxZMyeD-v-XgA7kOGgk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JSwMxFH64gHgRtS51jaAelKGzZSY9iIha1GrxoNDbmMkkUKjT2rrQv-av871ZqiJ68zKXSTJD8r3kbfkewK5JAq5CivobbVs-JRDGRFvpCVtpR2qhM0qhm1Zwce9ftXl7At7LuzCUVlnuidlGnfQU-chrZKqIkOi3aqZIi7g9axz3nyyqIEWR1rKcRg6Rph69ofk2PLo8w7Xec93G-d3phVVUGLAUEflbSrpGo8z6QSAppZ2imoK7oeJaOEbJup2EiWdrgacqT7i0JZp0RsQiEbhTcOnhuJMwHWJfkrGwPTb2bFHPCrU5nu9aeEQ7ZUQ1v7bncEr4JA5QwS3v-5n4Q9H9EaTNzr7GPMwVSis7yVG2ABM6XYTKSYoG--OI7bMsjTTzzy_CzE0Rra-A3-q96i4jf74cjBjd9KdkoMGQdVJG6Se547ejWKr7VK4BtdHREtz_yxwuw1TaS_UqMONox_j1UCtUi3wTy1DFVBnHBNxLEDhVsMt5ilRBYU6VNLrRJ_kyTW2ED2I-5ZFXhYNxl37O3_FX441y8qNClIfRJ_CqsDN-jUJIkRWZ6t5L1gZVHbce8Cqs5Is2_hrqlIgBjoMflqv4ZfDffmXt71_ZhhlEf3R92Wquw6ybQwkRtQFTz4MXvYmK0nO8lSGSwcN_i8AHMwIc2Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+urinary+biomarkers+in+pre-diabetic+nephropathy&rft.jtitle=Clinical+and+experimental+nephrology&rft.au=Garg%2C+Vikas&rft.au=Kumar%2C+Manish&rft.au=Mahapatra%2C+Himansu+Sekhar&rft.au=Chitkara%2C+Anubhuti&rft.date=2015-10-01&rft.issn=1342-1751&rft.eissn=1437-7799&rft.volume=19&rft.issue=5&rft.spage=895&rft.epage=900&rft_id=info:doi/10.1007%2Fs10157-015-1085-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10157_015_1085_3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1342-1751&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1342-1751&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1342-1751&client=summon |